Central Trust Company’s Braskem BAK Stock Holding History

Central Trust Company’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12	Closed	–	–	1363
2022 Q1	$0	Buy	+12	New	+$227	﹤0.01%	1345

Other funds holding BAK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return

Central Trust Company's BAK Position: Q2 2022 in Review

Central Trust Company sold out of Braskem (BAK) in Q2 2022, closing a stake of 12 shares.

Central Trust Company first reported a position in BAK in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 50 funds tracked by Wall St. Rank hold BAK as of Q2 2022.

Central Trust Company reported no remaining Braskem position as of Q2 2022 after selling out during the quarter.
Central Trust Company sold 12 Braskem shares in Q2 2022.
Central Trust Company first reported a position in Braskem in Q1 2022 and held it in 1 quarter.
Central Trust Company's Braskem position peaked at $0 in Q1 2022.
50 funds tracked by Wall St. Rank held Braskem as of Q2 2022.

Based on Central Trust Company's 13F filing for Q2 2022, filed 9 Aug 2022.